IL-22 induces an acute-phase response

Journal of Immunology

Volumn 185, Issue 9, 2010, Pages 5531-5538

  Liang, Spencer C ^a,c   Nickerson Nutter, Cheryl ^a   Pittman, Debra D ^a   Carrier, Yijun ^a   Goodwin, Debra G ^a   Shields, Kathleen M ^a   Lambert, Andre Jean ^b,d   Schelling, Scott H ^b   Medley, Quintus G ^a   Ma, Hak Ling ^a   Collins, Mary ^a   Dunussi Joannopoulos, Kyriaki ^a   Fouser, Lynette A ^a  

^a PFIZER INC   (United States)

^b Pfizer Global Research and Development   (United States)

^c Takeda San Francisco   (United States)

^d CHARLES RIVER LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; FIBRINOGEN; INTERLEUKIN 22; SERUM AMYLOID A; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ACUTE PHASE RESPONSE; ARTICLE; BIOCHEMICAL COMPOSITION; CELLULAR PARAMETERS; ERYTHROCYTE COUNT; FIBRINOGEN BLOOD LEVEL; INFLAMMATION; KIDNEY PROXIMAL TUBULE; NEUTROPHIL COUNT; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; THROMBOCYTE COUNT; THYMUS ATROPHY; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; IMMUNOLOGY; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY;

ACUTE-PHASE REACTION; ANIMALS; INTERLEUKINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 78149487314     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904091     Document Type: Article

References (53)

1. Wolk, K., and R. Sabat. 2006. Interleukin-22: a novel T-and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 17:367-380.
2. Wolk, K., S. Kunz, K. Asadullah, and R. Sabat. 2002. Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 168:5397-5402.
3. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203:2271-2279.
4. Martin, B., K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen. 2009. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31:321-330.
5. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. G. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31:331-341.
6. Colonna, M. 2009. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31:15-23.
7. Nograles, K. E., L. C. Zaba, A. Shemer, J. Fuentes-Duculan, I. Cardinale, T. Kikuchi, M. Ramon, R. Bergman, J. G. Krueger, and E. Guttman-Yassky. 2009. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J. Allergy Clin. Immunol. 123:1244-1252.
8. Duhen, T., R. Geiger, D. Jarrossay, A. Lanzavecchia, and F. Sallusto. 2009. Production of interleukin 22 but not interleukin 17 by a subset of human skinhoming memory T cells. Nat. Immunol. 10:857-863.
9. Trifari, S., C. D. Kaplan, E. H. Tran, N. K. Crellin, and H. Spits. 2009. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T (H)-17, T (H) 1 and T (H) 2 cells. Nat. Immunol. 10:864-871.
10. Eyerich, S., K. Eyerich, D. Pennino, T. Carbone, F. Nasorri, S. Pallotta, F. Cianfarani, T. Odorisio, C. Traidl-Hoffmann, H. Behrendt, et al. 2009. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 119:3573-3585.
11. Xie, M. H., S. Aggarwal, W. H. Ho, J. Foster, Z. Zhang, J. Stinson, W. I. Wood, A. D. Goddard, and A. L. Gurney. 2000. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 275:31335-31339.
12. Kotenko, S. V., L. S. Izotova, O. V. Mirochnitchenko, E. Esterova, H. Dickensheets, R. P. Donnelly, and S. Pestka. 2001. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J. Biol. Chem. 276:2725-2732.
13. Logsdon, N. J., B. C. Jones, K. Josephson, J. Cook, and M. R. Walter. 2002. Comparison of interleukin-22 and interleukin-10 soluble receptor complexes. J. Interferon Cytokine Res. 22:1099-1112.
14. Li, J., K. N. Tomkinson, X. Y. Tan, P. Wu, G. Yan, V. Spaulding, B. Deng, B. Annis-Freeman, K. Heveron, R. Zollner, et al. 2004. Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2. Int. Immunopharmacol. 4:693-708.
15. Renauld, J.-C. 2003. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat. Rev. Immunol. 3:667-676.
16. Wolk, K., E. Witte, U. Reineke, K. Witte, M. Friedrich, W. Sterry, K. Asadullah, H. D. Volk, and R. Sabat. 2005. Is there an interaction between interleukin-10 and interleukin-22? Genes Immun. 6:8-18.
17. Wolk, K., S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat. 2004. IL-22 increases the innate immunity of tissues. Immunity 21:241-254.
18. Aujla, S. J., Y. R. Chan, M. Zheng, M. Fei, D. J. Askew, D. A. Pociask, T. A. Reinhart, F. McAllister, J. Edeal, K. Gaus, et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275-281.
19. Zheng, Y., P. A. Valdez, D. M. Danilenko, Y. Hu, S. M. Sa, Q. Gong, A. R. Abbas, Z. Modrusan, N. Ghilardi, F. J. de Sauvage, and W. Ouyang. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14:282-289.
20. Boniface, K., F. X. Bernard, M. Garcia, A. L. Gurney, J. C. Lecron, and F. Morel. 2005. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174:3695-3702.
21. Ma, H. L., S. Liang, J. Li, L. Napierata, T. Brown, S. Benoit, M. Senices, D. Gill, K. Dunussi-Joannopoulos, M. Collins, et al. 2008. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J. Clin. Invest. 118:597-607.
22. Geboes, L., L. Dumoutier, H. Kelchtermans, E. Schurgers, T. Mitera, J.-C. Renauld, and P. Matthys. 2009. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum. 60:390-395.
23. Radaeva, S., R. Sun, H. N. Pan, F. Hong, and B. Gao. 2004. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39:1332-1342.
24. Sugimoto, K., A. Ogawa, E. Mizoguchi, Y. Shimomura, A. Andoh, A. K. Bhan, R. S. Blumberg, R. J. Xavier, and A. Mizoguchi. 2008. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118:534-544.
25. Zenewicz, L. A., G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, S. Stevens, and R. A. Flavell. 2008. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29:947-957.
26. Zenewicz, L. A., G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, M. Karow, and R. A. Flavell. 2007. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27:647-659.
27. Wolk, K., E. Witte, E. Wallace, W. D. Döcke, S. Kunz, K. Asadullah, H. D. Volk, W. Sterry, and R. Sabat. 2006. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36:1309-1323.
28. Baumann, H., and J. Gauldie. 1994. The acute phase response [see comment]. Immunol. Today 15:74-80.
29. Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340:448-454.
30. [Published erratum appears in 1999 N. Engl. J. Med. 340:1376.]
31. Steel, D. M., and A. S. Whitehead. 1994. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15:81-88.
32. Dumoutier, L., E. Van Roost, D. Colau, and J. C. Renauld. 2000. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl. Acad. Sci. USA 97:10144-10149.
33. Kozarsky, K. F., K. Jooss, M. Donahee, J. F. Strauss, III, and J. M. Wilson. 1996. Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nat. Genet. 13:54-62.
34. Bertone, A. L., D. D. Pittman, M. L. Bouxsein, J. Li, B. Clancy, and H. J. Seeherman. 2004. Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model. J. Orthop. Res. 22:1261-1270.
35. Liang, S. C., A. J. Long, F. Bennett, M. J. Whitters, R. Karim, M. Collins, S. J. Goldman, K. Dunussi-Joannopoulos, C. M. Williams, J. F. Wright, and L. A. Fouser. 2007. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J. Immunol. 179:7791-7799.
36. Ki, S. H., O. Park, M. Zheng, O. Morales-Ibanez, J. K. Kolls, R. Bataller, and B. Gao. 2010. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: Role of STAT3. Hepatology. DOI: 10.1002/hep. 23837.
37. Margarson, M. P., and N. Soni. 1998. Serum albumin: touchstone or totem? Anaesthesia 53:789-803.
38. Yeh, S.-S., K. Blackwood, and M. W. Schuster. 2008. The cytokine basis of cachexia and its treatment: are they ready for prime time? J. Am. Med. Dir. Assoc. 9:219-236.
39. Li, Q., M. A. Kay, M. Finegold, L. D. Stratford-Perricaudet, and S. L. Woo. 1993. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4:403-409.
40. Brand, S., J. Dambacher, F. Beigel, K. Zitzmann, M. H. Heeg, T. S. Weiss, T. Prüfer, T. Olszak, C. J. Steib, M. Storr, et al. 2007. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1019-G1028.
41. Ren, X., and L. M. Colletti. 2010. IL-22 is involved in liver regeneration after hepatectomy. Am. J. Physiol. Gastrointest. Liver Physiol. 298: G74-G80.
42. Gruver, A. L., and G. D. Sempowski. 2008. Cytokines, leptin, and stress-induced thymic atrophy. J. Leukoc. Biol. 84:915-923.
43. Carson, F. 1997. Nuclear and cytoplasmic staining. In: Histotechnology: A Self-Instructional Text, 2nd ed. F. L. Carson, ed. American Society for Clinical Pathology, Chicago, IL, p. 83-109.
44. Seely, J. 1999. Kidney. In Pathology of the Mouse. R. R. Maronpot, B. W. Gaul, and G. A. Boorman, eds. Cache River Press, Vienna, IL, p. 207-234.
45. Greaves, P. 2007. Urinary tract. In Histopathology of Preclinical Toxicity Studies, 3rd ed. P. Greaves, ed. Elsevier Science, New York, p. 570-660.
46. Pan, H., F. Hong, S. Radaeva, and B. Gao. 2004. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell. Mol. Immunol. 1:43-49.
47. Dambacher, J., F. Beigel, K. Zitzmann, M. H. Heeg, B. Göke, H. M. Diepolder, C. J. Auernhammer, and S. Brand. 2008. The role of interleukin-22 in hepatitis C virus infection. Cytokine 41:209-216.
48. Uhlar, C. M., and A. S. Whitehead. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265:501-523.
49. Su, S. B., W. Gong, J. L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189:395-402.
50. Cheng, N., R. He, J. Tian, P. P. Ye, and R. D. Ye. 2008. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 181:22-26.
51. Missé, D., H. Yssel, D. Trabattoni, C. Oblet, S. Lo Caputo, F. Mazzotta, J. Pène, J. P. Gonzalez, M. Clerici, and F. Veas. 2007. IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. J. Immunol. 178:407-415.
52. Ivanov, I. I., K. Atarashi, N. Manel, E. L. Brodie, T. Shima, U. Karaoz, D. Wei, K. C. Goldfarb, C. A. Santee, S. V. Lynch, et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485-498.
53. Kelly, K. J., B. Kluve-Beckerman, and J. H. Dominguez. 2009. Acute-phase response protein serum amyloid A stimulates renal tubule formation: studies in vitro and in vivo. Am. J. Physiol. Renal Physiol. 296: F1355-F1363.